PRODUCT REFERENCE GUIDE
|
|
|
- Barnaby King
- 7 years ago
- Views:
Transcription
1 PRODUCT REFERENCE GUIDE DRUGS OF ABUSE DAM ng/ml 50 DAM-U ng/ml 50 DAM-A ng/ml 50 DAM ng/ml 25 Tests/Canister AMP Amphetamine DAM ng/ml DAM-A ng/ml DAM ng/ml 25 DAM-U ng/ml 25 DAM-A ng/ml 25 BAR Barbiturates DBA DBA Tests/Canister 300 ng/ml DBA-102 DBA BUP Buprenorphine DBU DBU Tests/Canister 10 ng/ml DBU-102 DBU DBZ ng/ml 50 DBZ-A ng/ml 50 DBZ ng/ml 25 Tests/Canister BZO Benzodiazepines DBZ ng/ml DBZ-A ng/ml DBZ ng/ml 25 DBZ-A ng/ml 25
2 DCO ng/ml 50 DCO-U ng/ml 50 DCO ng/ml 25 Tests/Canister COC Cocaine DCO ng/ml DCO-U ng/ml DCO ng/ml 25 DCO-U ng/ml 25 DFT ng/ml 50 FTY Fentanyl/Norfentanyl DFT ng/ml KET Ketamine DKE ng/ml MDMA Ecstasy DMD ng/ml 50 DMD ng/ml 25 Tests/Canister DMD ng/ml DMD ng/ml 25 DME ng/ml 50 DME-U ng/ml 50 DME-A ng/ml 50 DME ng/ml 25 Tests/Canister MET Methamphetamine DME ng/ml DME-U ng/ml DME-A ng/ml DME ng/ml 25 DME-U ng/ml 25 DME-A ng/ml 25 MOP Morphine 300 DMO ng/ml 50 DMO ng/ml 25 Tests/Canister DMO ng/ml DMO ng/ml 25 DMQ ng/ml 50 MQL Methaqualone DMQ ng/ml
3 MTD Methadone DMT ng/ml 50 DMT ng/ml 25 Tests/Canister DMT ng/ml DMT ng/ml 25 OPI Opiate 2000 DOP ng/ml 50 DOP ng/ml 25 Tests/Canister DOP ng/ml DOP ng/ml 25 OXY Oxycodone DOX ng/ml 50 DOX ng/ml 25 Tests/Canister DOX ng/ml DOX ng/ml 25 PCP Phencyclidine DPC ng/ml 50 DPC ng/ml 25 Tests/Canister DPC ng/ml DPC ng/ml 25 PPX Propoxyphene DPP ng/ml 50 DPP ng/ml 25 Tests/Canister DPP ng/ml DPP ng/ml 25 TCA Tricyclic Antidepressants DTC ng/ml 50 DTC ng/ml 25 Tests/Canister DTC ng/ml DTC ng/ml 25 DTH ng/ml 50 DTH-B ng/ml 50 THC Marijuana DTH-C ng/ml 50 DTH ng/ml 25 Tests/Canister
4 DTH ng/ml DTH-B ng/ml THC Marijuana DTH-C ng/ml DTH ng/ml 25 DTH-B ng/ml 25 DTH-C ng/ml 25 DED ng/ml 50 DED-A ng/ml EDDP Methadone Metabolite DED ng/ml DED-A ng/ml DED ng/ml 25 DED-A ng/ml 25 Multi-Drug 2 Drug Screen Test Panel 2 Drugs DOA-124 See Insert 25 Multi-Drug 3 Drug Screen Test Panel 3 Drugs DOA-134 See Insert 25 Multi-Drug 4 Drug Screen Test Panel 4 Drugs DOA-144 See Insert 25 Multi-Drug 5 Drug Screen Test Panel 5 Drugs DOA-154 See Insert 25 Multi-Drug 6 Drug Screen Test Panel 6 Drugs DOA-164 See Insert 25 Multi-Drug 7 Drug Screen Test Panel 7 Drugs DOA-174 See Insert 25 Multi-Drug 8 Drug Screen Test Panel 8 Drugs DOA-184 See Insert 25 Multi-Drug 9 Drug Screen Test Panel 9 Drugs DOA-194 See Insert 25 Multi-Drug 10 Drug Screen Test Panel 10 Drugs DOA-1104 See Insert 25 Multi-Drug 11 Drug Screen Test Panel 11 Drugs DOA-1114 See Insert 25 Multi-Drug 12 Drug Screen Test Panel 12 Drugs DOA-1124 See Insert 25 Multi-Drug Screen Test Panel and Speciment Validity Test* DUA-1X4 See Insert 25 Multi-Drug Screen Test Panel and Speciment Validity Test* 2-12 Drugs DUB-1X4 See Insert 25 Multi-Drug Screen Test Panel and Speciment Validity Test* DUD-1X4 See Insert 25 Multi-Drug Multi-Line 2 Drug Screen Test 2 Drugs DOA-125 See Insert 25 Multi-Drug Multi-Line 3 Drug Screen Test 3 Drugs DOA-135 See Insert 25
5 Multi-Drug Multi-Line 4 Drug Screen Test 4 Drugs DOA-145 See Insert 25 Multi-Drug Multi-Line 5 Drug Screen Test 5 Drugs DOA-155 See Insert 25 Multi-Drug Multi-Line 6 Drug Screen Test 6 Drugs DOA-165 See Insert 25 Multi-Drug Multi-Line 7 Drug Screen Test 7 Drugs DOA-175 See Insert 25 Multi-Drug Multi-Line 8 Drug Screen Test 8 Drugs DOA-185 See Insert 25 Multi-Drug Multi-Line 9 Drug Screen Test 9 Drugs DOA-195 See Insert 25 Multi-Drug Multi-Line 10 Drug Screen Test 10 Drugs DOA-1105 See Insert 25 Multi-Drug Multi-Line 11 Drug Screen Test 11 Drugs DOA-1115 See Insert 25 Multi-Drug Multi-Line 12 Drug Screen Test 12 Drugs DOA-1125 See Insert 25 Multi-Drug Multi-Line 2 Drug Screen Test Panel with Integrated Cup 2 Drugs DOA-127 See Insert 25 Multi-Drug Multi-Line 3 Drug Screen Test Panel with Integrated Cup 3 Drugs DOA-137 See Insert 25 Multi-Drug Multi-Line 4 Drug Screen Test Panel with Integrated Cup 4 Drugs DOA-147 See Insert 25 Multi-Drug Multi-Line 5 Drug Screen Test Panel with Integrated Cup 5 Drugs DOA-157 See Insert 25 Multi-Drug Multi-Line 6 Drug Screen Test Panel with Integrated Cup 6 Drugs DOA-167 See Insert 25 Multi-Drug Multi-Line 7 Drug Screen Test Panel with Integrated Cup 7 Drugs DOA-177 See Insert 25 Multi-Drug Multi-Line 8 Drug Screen Test Panel with Integrated Cup 8 Drugs DOA-187 See Insert 25 Multi-Drug Multi-Line 9 Drug Screen Test Panel with Integrated Cup 9 Drugs DOA-197 See Insert 25 Multi-Drug Multi-Line 10 Drug Screen Test Panel with Integrated Cup 10 Drugs DOA-1107 See Insert 25 Multi-Drug Multi-Line 11 Drug Screen Test Panel with Integrated Cup 11 Drugs DOA-1117 See Insert 25 Multi-Drug Multi-Line 12 Drug Screen Test Panel with Integrated Cup 12 Drugs DOA-1127 See Insert 25 Multi-Drug Multi-Line Drug Screen test Panel with Integrated Cup and Specimen Validity Test* Multi-Drug Multi-Line Drug Screen test Panel with Integrated Cup and Specimen Validity Test* Multi-Drug Multi-Line Drug Screen test Panel with Integrated Cup and Specimen Validity Test* Multi-Drug Multi-Line 2 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 3 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 4 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 5 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 6 Drug Screen Test Panel with E-Z Split Key Cup DUA-1X7 See Insert Drugs DUB-1X7 See Insert 25 DUD-1X7 See Insert 25 2 Drugs DBO-127 See Insert 25 3 Drugs DBO-137 See Insert 25 4 Drugs DBO-147 See Insert 25 5 Drugs DBO-157 See Insert 25 6 Drugs DBO-167 See Insert 25
6 Multi-Drug Multi-Line 7 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 8 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 9 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 10 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 11 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line 12 Drug Screen Test Panel with E-Z Split Key Cup Multi-Drug Multi-Line Drug Screen test Panel with E-Z Split Key Cup and Specimen Validity Test* Multi-Drug Multi-Line Drug Screen test Panel with E-Z Split Key Cup and Specimen Validity Test* Multi-Drug Multi-Line Drug Screen test Panel with E-Z Split Key Cup and Specimen Validity Test* 7 Drugs DBO-177 See Insert 25 8 Drugs DBO-187 See Insert 25 9 Drugs DBO-197 See Insert Drugs DBO-1107 See Insert Drugs DBO-1117 See Insert Drugs DBO-1127 See Insert 25 DBA-1X7 See Insert Drugs DBB-1X7 See Insert 25 DBD-1X7 See Insert 25 Multi-Line Screen 2 Test Panel with Integrated icup 2 Drugs DGO-127 See Insert 25 Multi-Line Screen 3 Test Panel with Integrated icup 3 Drugs DGO-137 See Insert 25 Multi-Line Screen 4 Test Panel with Integrated icup 4 Drugs DGO-147 See Insert 25 Multi-Line Screen 5 Test Panel with Integrated icup 5 Drugs DGO-157 See Insert 25 Multi-Line Screen 6 Test Panel with Integrated icup 6 Drugs DGO-167 See Insert / Multi-Line Screen 7 Test Panel with Integrated icup 7 Drugs DGO-177 See Insert / Multi-Line Screen 8 Test Panel with Integrated icup 8 Drugs DGO-187 See Insert / Multi-Line Screen 9 Test Panel with Integrated icup 9 Drugs DGO-197 See Insert / Multi-Line Screen 10 Test Panel with Integrated icup 10 Drugs DGO-1107 See Insert / Multi-Line Screen 11 Test Panel with Integrated icup 11 Drugs DGO-1117 See Insert / Multi-Line Screen 12 Test Panel with Integrated icup 12 Drugs DGO-1127 See Insert / Multi-Line Screen Test Panel with Integrated icup and Specimen Validity Test* DGA-1X7 See Insert 25 Multi-Line Screen Test Panel with Integrated icup and Specimen Validity Test* 2-12 Drugs DGB-1X7 See Insert 25 Multi-Line Screen Test Panel with Integrated icup and Specimen Validity Test* DGD-1X7 See Insert 25 E-Z Start Multi-Drug 2 Test Cup 2 Drugs DEO-127 See Insert 25 E-Z Start Multi-Drug 3 Test Cup 3 Drugs DEO-137 See Insert 25 E-Z Start Multi-Drug 4 Test Cup 4 Drugs DEO-147 See Insert 25 E-Z Start Multi-Drug 5 Test Cup 5 Drugs DEO-157 See Insert 25
7 E-Z Start Multi-Drug 6 Test Cup 6 Drugs DEO-167 See Insert 25 E-Z Start Multi-Drug 7 Test Cup 7 Drugs DEO-177 See Insert 25 E-Z Start Multi-Drug 8 Test Cup 8 Drugs DEO-187 See Insert 25 E-Z Start Multi-Drug 9 Test Cup 9 Drugs DEO-197 See Insert 25 E-Z Start Multi-Drug 10 Test Cup 10 Drugs DEO-1107 See Insert 25 E-Z Start Multi-Drug 11 Test Cup 11 Drugs DEO-1117 See Insert 25 E-Z Start Multi-Drug 12 Test Cup 12 Drugs DEO-1127 See Insert 25 E-Z Start Multi-Drug Test Cup and Specimen Validity Test* DEA-1X7 See Insert 25 E-Z Start Multi-Drug Test Cup and Specimen Validity Test* 2-12 Drugs DEB-1X7 See Insert 25 E-Z Start Multi-Drug Test Cup and Specimen Validity Test* DED-1X7 See Insert 25 Multi-CLIN Drug Screen Test DCB-1115 See Insert 25 Saliva Alcohol Oral Fluid DAL-701 See Insert mm Adulteration s (Creatinine/Nitrite/Glutaraldehyde/pH/Specific Gravity/ Oxidant) 6 parameters DUC-111 See Insert 25 * Adulteration / Specimen Validity Tests are not regulated by FDA ** Class I specimen transport and storage container (exempt from premarket notification) WOMEN'S HEALTH hcg Pregnancy FHC miu/ml FHC-U miu/ml 50 FHC miu/ml 25*
8 WOMEN'S HEALTH (Continued) FHC-U miu/ml 25* FHC miu/ml FHC-U miu/ml FHC miu/ml 25 hcg Pregnancy /Serum FHC miu/ml 50 FHC-U miu/ml 50 FHC miu/ml 25* FHC-U miu/ml FHC miu/ml FHC-U miu/ml FLH-101 miu/ml FLH-U miu/ml 50 LH Ovulation FLH-111 miu/ml 25* FLH-102 miu/ml FLH-U miu/ml FSH Menopause FFS miu/ml *Also available in canisters of 20 or 30 INFECTIOUS DISEASES Chlamydia Swab/ ICH-502 See insert 20** HBV Hepatitis B Virus Combo Serum/Plasma IHB-355 See Insert 25 HBsAb Hepatitis B Surface Antibody Serum/Plasma IHBsb IHBsb * See insert IHBsb-302 IHBsb mm
9 INFECTIOUS DISEASES (Continued) HBsAg Hepatitis B Surface Antigen Serum/Plasma IHBsg IHBsg * IHBsg-302 IHBsg-302C See insert IHBsg-1 50 IHBsg * 3.3 mm IHBsg-2 HBsAg Ultra Hepatitis B Surface Antigen Serum/Plasma IHBsg-U IHBsg-U311 See insert 25* IHBsg-U302 HBeAb Hepatitis B Envelope Antibody Serum/Plasma IHBeb-302 See insert HBeAg Hepatitis B Envelope Antigen Serum/Plasma IHBeg-302 See insert HBcAb Hepatitis B Core Antibody Serum/Plasma IHBcb-302 See insert IHC Serum/Plasma IHC-302 HCV Hepatitis C Virus IHC-302C See Insert IHC-1 50 IHC-2 HBsAg and HCV Combo Serum/Plasma Combo IHBC-325 See insert Serum/Plasma IHI-U302 IHI-1 50 HIV 1/2 Human Immunodeficiency Virus 1/3 See insert IHI * IHI-2 HIV 1/2/O Tri-line Human Immunodeficiency Virus 1/2/O IHI-T2 See Insert 10 /
10 INFECTIOUS DISEASES (Continued) H. pylori Serum/Plasma IHP-302 IHP-1 See Insert 50 IHP-2 Malaria P.f. Whole Blood IMA-1 50 See Insert IMA-2 Mono IMO-1 20 IMO-411 See Insert 25 Tests/Canister IMO-2 20 IST-501 See Insert 25** Strep A Throat Swab IST Tests/Canister IST ** Twist IST-502T 25** 5.0 mm Serum/Plasma ISY-U302 Syphilis ISY-U1 50 See Insert ISY-U411 25* ISY-U2 *Also available in canisters of 20 or 30 **Includes swabs and/or controls ONCOLOGY AFP Alpha-Fetoprotein TAF-2 10 ng/ml CEA Carcinoembryonic Antigen TCE-2 5 ng/ml FOB Fecal Occult Blood Feces TFO ng/ml 6 μg/g 25 Telephone: Fax: Summers Ridge Road. San Diego, CA USA info@innovaconinc.com
DICHIARAZIONE DI CONFORMITA
DICHIARAZIONE DI CONFORMITA DECLARATION OF CONFORMITY Fabbricante: SCREEN Italia s.r.l., via Volumnia 40/B, 06135 Ponte San Giovanni (Perugia) Manufacturer: SCREEN Italia s.r.l., via Volumnia 40/B, 06135
Toxicology CPT Code Changes for 2016
Beginning January 1, 2016, CMS deleted all 2015 drug testing G codes and will continue to not recognize the AMA CPT codes for drug testing. CMS created three G codes for presumptive testing and four G
Collection Instructions for ARUP Drug Screen Kit #49204
Collection Instructions for ARUP Drug Screen Kit #49204 Manufacturer Purpose of Kit / Reagent (tests) Kit / Reagent Contents (list components) Other Supplies Needed ARUP Laboratories For Point of Collection
C. The prospective employee must thoroughly read the LFCC Pre-Employment Drug
Pre-Employment Drug Screening Policy Policy No. 40001 Effective Date March 2006 Revision Date Revision No. Approved: John J. Ski Sygielski and President s Cabinet Date: March 2006 1.0 Purpose Substance
Rapid Screening Tests
Rapid Screening Tests Infectious Diseases Cardiac Marker Tumor Markers Pregnancy Rheumatology Allergy Drugs of Abuse > For rapid and cost-effective diagnosis > Accurate, reliable results > Easy to use
SOUTHEASTERN OKLAHOMA STATE UNIVERSITY. ALCOHOL, TOBACCO, and OTHER DRUG-EDUCATION GUIDELINES. and the. DRUG-TESTING PROGRAM for STUDENT-ATHLETES
SOUTHEASTERN OKLAHOMA STATE UNIVERSITY ALCOHOL, TOBACCO, and OTHER DRUG-EDUCATION GUIDELINES and the DRUG-TESTING PROGRAM for STUDENT-ATHLETES Student-athletes are responsible for anything they ingest.
REACH AIR MEDICAL SERVICES SUBSTANCE ABUSE POLICY FOR APPLICANTS APPLYING FOR SAFETY-SENSITIVE POSITIONS
EFFECTIVE DATE: 06/01/2013 REACH AIR MEDICAL SERVICES SUBSTANCE ABUSE POLICY FOR APPLICANTS APPLYING FOR SAFETY-SENSITIVE POSITIONS (FOR TESTING TO BE CONDUCTED IN CALIFORNIA [excluding the City of San
I.M.P.A.C.T. Revised. SUBSTANCE ABUSE TESTING POLICY Part I. PROCEDURE MANUAL Part II
I.M.P.A.C.T. Revised SUBSTANCE ABUSE TESTING POLICY Part I & PROCEDURE MANUAL Part II REVISED June 2011 Revised Substance Abuse Policy Part I Table of Contents I. Preface I. Statement of Policy.........
Understanding Drug Screens & PharmCAS Drug Screening Program Overview. Suzi Arant, Senior Business Developer July 8, 2011
Understanding Drug Screens & PharmCAS Drug Screening Program Overview Suzi Arant, Senior Business Developer July 8, 2011 Presentation Overview Drug Screening in Healthcare Drug Screening Panels Drugs of
Professional Product List 2015
Trade diagnostical products for clinical laboratories products for life. Professional Product List 2015 CLINICAL CHEMISTRY Occupational Medicine Drugs of Abuse TDM High Diagnostic Sensitivity and Specificity
Substance Abuse Prevention Program
Planning, Design and Construction 14528 S Outer Forty Suite 100 Chesterfield, MO 63017 (314) 628-3494 (314) 628-3715 Substance Abuse Prevention Program REFERENCES: In an effort to create a safe workplace,
FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze
FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze BENEFITS AND PRICING Q: What benefits does Oral-Eze present? A: The Oral-Eze Oral Fluid Collector has a built-in indicator for determining
The CPT code for Human papillomavirus (HPV) has changed from 87621 to 87624. This code (87624) covers testing for HPV High Risk genotypes.
January 2015 2015 CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural Terminology (CPT) Coding Manual on an annual basis. For 2015, the AMA made several
LC-MS for Pain Management Support. Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories
LC-MS for Pain Management Support Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories Outline Overview of drug testing, as a component of the therapeutic plan, in the management of chronic
PAYMENT POLICY STATEMENT
PAYMENT POLICY STATEMENT Original Effective Date Next Annual Review Date Last Review / Revision Date 01/01/2014 04/05/2017 04/05/2016 Policy Name Policy Number Drug Screening Tests PY-0020 Policy Type
3.1. The procedure shall be applicable to all University employees.
LINCOLN UNIVERSITY Procedure: Confirmatory Testing for Substance Abuse Procedure Number: HRM 113p Effective Date: October 2008 Revisions: Review Officer: Chief Human Resources Officer 1. Purpose 1.1. It
LC-MS for Pain Management Support
LC-MS for Pain Management Support Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories Outline Overview of drug testing, as a component of the therapeutic plan, in the management of chronic
DRUG SCREENING POLICY AND PROCEDURES Effective August 31, 2015
DRUG SCREENING POLICY AND PROCEDURES Effective August 31, 2015 The signatory parties recognize that drug abuse is an illness that creates serious problems for workers, their families, the workplace and
Why do employers drug test? How is drug testing conducted and how accurate is it?
Workplace Drug Testing Drug testing is one action an employer can take to determine if employees or job applicants are using drugs. It can identify evidence of recent use of alcohol, prescription drugs
HELPING YOUR BUSINESS DO MORE Webinar Series
HELPING YOUR BUSINESS DO MORE Webinar Series The Employers Council of Iowa, the Greater Des Moines Partnership, Kaplan University and Iowa Works bring you a series of educational webinars. These webinars
Room Temp: 8 Hr. Room Temp: 8Hr. Room Temp: ASAP. Refrigerated (2-8C): 3D. Room Temp: ASAP. Refrigerated (2-8C): 3D
Diabetes Chem Panel (Glu, Trig, Chol, HDL, LDL, Chol:HDL Ratio, AST, ALT, BUN, Creat, GFR, Na, K, Cl, CO2, Ca) ANMC Lab Test Requirements Updated 4/7/15 Key: Room Temp (20-25C), Refrigerated (2-8C), (-15
The potential of oral fluid as a specimen in various drug testing programs
The potential of oral fluid as a specimen in various drug testing programs *Christine Moore, Cynthia Coulter, Katherine Crompton, Warren Rodrigues, Michael Vincent, James Soares Immunalysis Corporation,
AristaBiologicalsInc.
AristaBiologicalsInc. 2015 Rawmaterialsfor diagnosticasaymanufacturing. www.aristabiologicalsinc.com 2015 Catalog Contents Introduction... 3 Custom Services Consultation Services... 4 Feasibility Studies...
Author: Leo Cangianelli, The Walsh Group, 6701 Democracy Blvd., Suite 300, Bethesda, MD 21807, U.S.A.
ROSITA II Project: "Evaluation of the Draeger 'Uplink' and Securetec 'DrugWipe 5' Oral Fluid Drug Testing Devices in Hillsborough County, Florida 2005-2006 Author: Leo Cangianelli, The Walsh Group, 6701
Employer Drug Testing Solutions
Employer Drug Testing Solutions A broad range of testing and collection options backed by a service-oriented culture that s committed to showing we re there when you need us. Choose drug testing to help
Hillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction
Hillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction Drug testing beyond the health care and criminal justice systems has
Drug Testing Reference Tables for Drug Courts
Drug Testing Reference Tables for Drug Courts July, 2009 Page 1 TABLE I. Specimen Detection Period Advantages Disadvantages URINE SWEAT (patch) ORAL FLUID (saliva) Provides a profile of both current and
The DRE DUI & DRUGS. Captain George Crum Fullerton Police Department
The DRE DUI & DRUGS Captain George Crum Fullerton Police Department What is a DRE? Drug Recognition Expert Experienced officer Selected by their department Special training in detecting drug influence/impairment
BUILDING A BRIGHTER FUTURE... FOR A BETTER TOMORROW. OraSure Technologies, Inc. 2007 ANNUAL REPORT
BUILDING A BRIGHTER FUTURE... FOR A BETTER TOMORROW OraSure Technologies, Inc. 2007 ANNUAL REPORT To Our Stockholders I am extremely pleased to report that 2007 was an excellent year for our Company on
[Intentionally left blank]
![[Intentionally left blank]](/thumbs/36/17500684.jpg "[Intentionally left blank]")
READER USER MANUAL [Intentionally left blank] [Intentionally left blank] Contents Introduction... 1 Intended Use... 1 Product Overview... 3 Box Contents... 5 Specifications... 5 Set Up... 6 Installation...
SERVING GRANITE CITY, MITCHELL, AND PONTOON BEACH
2001 Delmar Avenue Granite City, IL 62040-6238 618-452-6238 smrld.org Tina Hubert Executive Director SERVING GRANITE CITY, MITCHELL, AND PONTOON BEACH SMRLD Drug and Alcohol Free Workplace Policy Purpose
This packet contains information and forms needed for Nurse Aide Students:
Healthcare Continuing Education PO Box 35009 Charlotte, NC 28235 NURSE AIDE I Information packet This packet contains information and forms needed for Nurse Aide Students: Topic Page Where to Start? 2
Pain Medication Management Program Monitors Patient Compliance
PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your
MOSAIC DES MOINES Alcohol/Drug Free Workplace Policy
MOSAIC DES MOINES Alcohol/Drug Free Workplace Policy Purpose: To help safeguard employee health, provide a safe and productive workplace, and supply our people served with high quality service, Mosaic
I.M.P.A.C.T. National Drug Testing and Substance Abuse Program and Guidelines
IRONWORKER MANAGEMENT PROGRESSIVE ACTION COOPERATIVE TRUST I.M.P.A.C.T. National Drug Testing and Substance Abuse Program and Guidelines Effective The processes and procedures outlined may be used as a
Health Safety Environmental Program SUBSTANCE ABUSE PREVENTION
Effective Date 06/01/2011 PROGRAM The policies and procedures of this substance abuse prevention program apply to all company operations. This program facilitates compliance with the Arkansas Drug Free
CERTIFICATE OF COMPLIANCE OF
CERTIFICATE OF COMPLIANCE OF Name of Contractor Company GOLDEN TRIANGLE CONTRACTOR SUBSTANCE AND ALCOHOL ABUSE PROGRAM November 2002 Edition Adopted and implemented by [Name of Contractor Company] ( Company
Drug Testing and Product Training
Drug Testing and Product Training TABLE OF CONTENTS A. Drugs of Abuse and Testing 1. Trends in Drug Use 2. Who s Using Drug Testing? 3. Types of Testing: Screening and Confirmation 4. Types of Testing
Pennsylvania Hospital & Surgery Center ADMINISTRATIVE POLICY MANUAL
Page 1 Issued: May 2003 Committee Approval: Human Resources Administrative Policy Review Committee: May 2004 May 2005 May 2007 June 2008 Attachment(s): Consent Acknowledgement Form Related Policies: POLICY
Alcoholism, Drug Addiction, and the Road to Recovery
Alcoholism, Drug Addiction, and the Road to Recovery Life on the Edge Barry Stimmel, MD The Haworth Medical Press An Imprint of The Haworth Press, Inc. New York London Oxford CONTENTS Preface Acknowledgments
2015 CPT Code Changes ACL Test
Changes ACL Test Test Description UCOMP DRUG SCREEN COMPLETE 80100 80303 G0431 UDINV DRUG INVESTIGATION 80100 80303 G0431 UTLC THIN LAYER CHROMATOGRAPHY DRUG SCREEN 80100 80303 G0431 UNIC NICOTINE, URINE
Tests Impacted by 2015 CPT Changes
Toxicology Changes for 2015 HPV Examples of Toxicology Panels Molecular Pathology, FISH and Anatomic Pathology 1 Toxicology Changes for 2015 80100 Test Code Dos Test Name 2015 2015 Medicare 5229 Drug Screen,
Central Government Laboratory Department of Health and Environment
Central Government Laboratory Department of Health and Environment Overview who we are and what we do What is available and what is protocol for good science Sample collection Screening Tests Confirmation
Practical Aspects of Drug Testing in Human Hair
Practical Aspects of Drug Testing in Human Hair Laboratory Perspective James A. Bourland, Ph.D., DABFT FOR INTERNAL USE ONLY. NOT FOR PRINT OR DISTRIBUTION Overview of Collection Process FOR INTERNAL USE
RANDOM DRUG AND ALCOHOL TESTING OF STUDENTS PARTICIPATING IN COMPETITIVE ACTIVITIES
Administrative Rule RANDOM DRUG AND ALCOHOL TESTING OF STUDENTS PARTICIPATING IN COMPETITIVE ACTIVITIES Code JCDAE-R Issued 06/14 Testing Coordinator The athletic director will coordinate and supervise
DRUG AND ALCOHOL TESTING REGULATIONS
DRUG AND ALCOHOL TESTING REGULATIONS Title 15: Mississippi State Department of Health Part 3: Office of Health Protection Subpart 1: Health Facilities Licensure and Certification Post Office Box 1700 Jackson,
The Conco Companies - Non Commercial Driver. Drug and Alcohol Policy Program
The Conco Companies - Non Commercial Driver Drug and Alcohol Policy Program 1 2 I. Purpose Statement The purpose of The Conco Companies Drug & Alcohol Policy is to create, encourage and enforce a safe
Bermuda Hospitals Board Drug Screening Programme
Bermuda Hospitals Board Drug Screening Programme Tiana Outerbridge, Employee Health Services Manager Dr. Cathryn Siddle, Employee Health Services Physician Angela Fraser-Pitcher, Human Resources Director
An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse
Drug Testing An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Printed on August 18, 2016 1:59 pm CST 2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.
Department of Health & Human Services (DHHS) Centers for Medicare & Medicaid Services (CMS) Transmittal 3550 Date: June 24, 2016
CMS Manual System Pub 100-04 Medicare Claims Processing Department of Health & Human Services (DHHS) Centers for Medicare & Medicaid Services (CMS) Transmittal 3550 Date: June 24, 2016 Change Request 9687
ORAL ROBERTS UNIVERSITY AMENDED DRUG AND ALCOHOL TESTING PLAN
ORAL ROBERTS UNIVERSITY AMENDED DRUG AND ALCOHOL TESTING PLAN Effective November 1, 2011 CONTENTS I. INTRODUCTION 4 A. Statement of Policy 4 B. Nature and Type of Drug and Alcohol Testing 4 C. Drugs for
ALPHA RECOVERY CENTERS Application & Screening Data
ALPHA RECOVERY CENTERS Application & Screening Data I am applying for admission to: Alpha Recovery Centers Atlanta Alpha Recovery Centers - Brunswick Thank you for your interest in Alpha Recovery Centers.
Neurotransmitters Made Easy: The Mood Teeter-Totter
Neurotransmitters Made Easy: The Mood Brad Lander PhD, LICDC Clinical Director / Psychologist Talbot Hall - Addiction Medicine at The Ohio State University Wexner Medical Center Key Point #1 Thinking and
CUT-OFF CONCENTRATIONS FOR DRUGS OF ABUSE IN SALIVA FOR DUI, DWI OR OTHER DRIVING-RELATED CRIMES
CUT-OFF CONCENTRATIONS FOR DRUGS OF ABUSE IN SALIVA FOR DUI, DWI OR OTHER DRIVING-RELATED CRIMES Vina SPIEHLER 1, Dene BALDWIN 2, Christopher HAND 2 1 DABFT, Newport Beach, United States of America 2 Cozart
Technical Note. Introduction. Edward J. Cone. Lance Presley, Michael Lehrer, William Seiter, and Melissa Smith
Technical Note Oral Fluid Testing for Drugs of Abuse: Positive Prevalence Rates by Intercept Immunoassay Screening and GC MS MS Confirmation and Suggested Cutoff Concentrations * Edward J. Cone ConeChem
Drug-Testing Program. Overview
Sunnyvale Independent School District DrugTesting and Rehabilitation Program 20132014 DrugTesting Program Overview The District requires drug testing of any student in grade 912 who chooses to participate
Patient Information Sheet
Healthcare Worker exposure to a patient s blood What is a healthcare worker exposure? Patient Information Sheet Occasionally, health care workers come into contact with the blood or body fluids of their
OU MEDICAL CENTER Human Resource Policy and Procedure Manual. Subject: Drug and Alcohol
OU MEDICAL CENTER Human Resource Policy and Procedure Manual Subject: Drug and Alcohol Section: HR 6-10 Page: 1 of 5 Origination Date: 6/2004 Revision Date: 2/2006, 9/2008, 7/2009 Coverage: All OUMC employees
Santa Rosa Consolidated Schools Santa Rosa, New Mexico Student Activities Drug/Alcohol Testing Policy
1 Santa Rosa Consolidated Schools Santa Rosa, New Mexico Student Activities Drug/Alcohol Testing Policy The Santa Rosa Consolidated Schools Board of Education, in order to: Help prevent students participating
THE DRUG AND ALCOHOL SCREENING PROGRAM
THE DRUG AND ALCOHOL SCREENING PROGRAM Revision 8- June 1 2014 Table of Contents Page Section 1 Introduction 3 Section 2 Commitment to Confidentiality 3 Section 3 Card Identification System 4 Section 4
CITY OF MONTEREY Substance Abuse Policy General Employees of Monterey (GEM) July 1, 2003
Page 1 ATTACHMENT C CITY OF MONTEREY Substance Abuse Policy General Employees of Monterey (GEM) July 1, 2003 PURPOSE This policy provides guidelines for the detection and deterrence of alcohol and drug
Appropriate Use of UDT to Improve Patient Care
Published on OpioidRisk (http://www.opioidrisk.com) Home > Urine Drug Testing Urine Drug Testing This guide provides: Download Entire Guide [1] Appropriate use of Urine Drug Testing (UDT) to improve patient
Policy Statement Regarding an Alcohol and Drug-Free Workplace
Policy Statement Regarding an Alcohol and Drug-Free Workplace Date Revised Date Reviewed Date Issued October 1, 2013 Functional Responsibility Human Resources on the Stockton campus is responsible for
How To Test For Drugs And Alcohol
Group Policy GE Healthcare issued By. HUMAN RESOURCES NO 2.7 To be Reviewed: November 2013 Date 9/13/10 subject DRUG-FREE WORKPLACE I. INTRODUCTION GE Healthcare believes that its employees are the Company's
Clinical Drug Testing in Primary Care
Clinical Drug Testing in Primary Care Technical Assistance Publication Series TAP 32 Clinical Drug Testing in Primary Care TAP Technical Assistance Publication Series 32 U.S. DEPARTMENT OF HEALTH AND
PtProtect Pain Medication Management Program Monitors Patient Compliance
PHYSICIAN UPDATE 2013 Edition PtProtect Pain Medication Management Program Monitors Patient Compliance The PtProtect (Patient Protect) program offers pain medication management panels designed to improve
NALCOR ENERGY ALCOHOL AND DRUG PROGRAM REQUIREMENTS FOR CONTRACTORS
NALCOR ENERGY ALCOHOL AND DRUG PROGRAM REQUIREMENTS FOR CONTRACTORS At Nalcor Energy, safety is our top priority. We take collective pride in our commitment to ensuring employees, contractors and visitors
Urine Drug Testing Methadone 101 Methadone for hospitalists
Urine Drug Testing Methadone 101 Methadone for hospitalists Dr. Patricia Mark MB, BCh LEARNING OBJECTIVES Clarify the purpose of urine drug testing Distinguish between UDT for detection of illicit drug
Generation Drug Free Workplace Policy for Contractor Personnel
Generation Drug Free Workplace Policy for Contractor Personnel Revision: 04 Date: 05-06-15 Submitted: Electronic approval pages are archived in CSR Portfolio. Contact K. Kemp for a copy. Reviewed: Reviewed:
LCD for Viral Hepatitis Serology Tests
LCD for Viral Hepatitis Serology Tests Applicable CPT Code(s): 86692 Antibody; Hepatitis, Delta Agent 86704 Hepatitis B Core Antibody (HBcAb); Total 86705 Hepatitis B Core Antibody (HBcAb); IgM Antibody
MA Bulletin 01-06-06 Keystone Mercy Health Plan is implementing the following changes:
September 1, 2006 Dear Keystone Mercy Provider: Effective July 17, 2006, the Pennsylvania Department of Public Welfare (DPW) has end-dated several local procedure codes pertaining to services offered in
POLICIES PROCEDURES AND SANCTIONS FOR ALCOHOL AND OTHER DRUGS
WESTCHESTER COLLEGE OF NURSING AND ALLIED HEALTH 8939 S. Sepulveda Boulevard, Suite 302 Los Angeles, CA 90045 POLICIES PROCEDURES AND SANCTIONS FOR ALCOHOL AND OTHER DRUGS Introduction WESTCHESTER COLLEGE
Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)
Appendix D: Urine Drug Testing for Monitoring Opioid Therapy i. Monitoring opioid therapy with urine drug testing (UDT) ii. UDT algorithm for monitoring opioid therapy iii. UDT clinical vignettes iv. Frequently
Drugs and Drug Po Hey. The Control of Consciousness. Alteration. Second Edition. Clayton J. Mosher. Washington State University Vancouver
Drugs and Drug Po Hey The Control of Consciousness Alteration Second Edition Clayton J. Mosher Washington State University Vancouver Scott M. Akins Oregon State University (DSAGE Los Angeles London New
NORTH AMERICAN SUBSTANCE ABUSE PROGRAM (NASAP)
NORTH AMERICAN SUBSTANCE ABUSE PROGRAM (NASAP) 1.0 INTRODUCTION The Owner Members of the Houston Business Roundtable (HBR) recognize the benefits of having a safe and substance abuse-free work force. A
Urine drug screens. Screening Methods
Screening Methods Urine drug screens Urine drug screens are generally performed using either immunoassays or gas chromatography-mass spectrometry (GC-MS). 2 Immunoassay UDS contain specific antibodies
Drug and Alcohol Abuse Prevention Information
Drug and Alcohol Abuse Prevention Information Fine Mortuary College (FMC) is committed to providing a drug-free environment for all college students and employees. Under the Drug-free Workplace Act and
Drug Abuse Trends in the Seattle-King County Area: 2014
Drug Abuse Trends in the Seattle-King County Area: 2014 June 12, 2015 Caleb Banta-Green 1, T. Ron Jackson 2, Steve Freng 3, Michael Hanrahan 4, Cynthia Graff 5, John Ohta 6, Mary Taylor 7, Richard Harruff
HEAT AND FROST INSULATORS AND ALLIED WORKERS LOCAL 45 JOINT APPRENTICESHIP AND TRAINING COMMITTEE DRUG-FREE SUBSTANCE ABUSE POLICY AND PROCEDURE
HEAT AND FROST INSULATORS AND ALLIED WORKERS LOCAL 45 JOINT APPRENTICESHIP AND TRAINING COMMITTEE I. PURPOSE DRUG-FREE SUBSTANCE ABUSE POLICY AND PROCEDURE The purpose of this Substance Abuse Policy (hereinafter
DUI in Southern Ohio MATT 2006
DUI in Southern Ohio MATT 2006 Laureen J. Marinetti, M.S., Ph.D. Chief Toxicologist Montgomery County Coroner s s Office & Miami Valley Regional Crime Lab (MVRCL) Dayton, Ohio Region The MVRCL is a regional
Drug Utilization Is On The Rise
Objectives Identify the clinical issues related to opioid prescribing for chronic pain indications Define the clinical needs and expectations of urine drug testing in pain management Address preanalytical
Premarital Screening Standard. Premarital Screening and Counseling Program. Version 1.1
Premarital Screening Standard Premarital Screening and Counseling Program Version 1.1 July 2013 Table of Contents Page Table of Contents 1 Table of Appendixes 2 Abbreviation list 3 Introduction 4 PS.1
ROYAL HOSPITAL FOR WOMEN
HEPATITIS B POSITIVE MOTHERS AND THEIR BABIES This LOP is developed to guide clinical practice at the Royal Hospital for Women. Individual patient circumstances may mean that practice diverges from this
Appendix 3 Exposure Incident Report Form
Appendix 3 Exposure Incident Report Form January, 2015 Page 1 of 6 Please see the following pages for the Exposure Incident Report Form. Guidelines for the Management of Exposure to Blood and Body Fluids
MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code
MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code Initial Assessment And Intervention This Code Can Be Used Only Once A Year For First Appointment Medical Nutrition Therapy
Drug Abuse Trends in the Seattle/King County Area: 2009
Drug Abuse Trends in the Seattle/King County Area: 2009 Caleb Banta-Green 1, T. Ron Jackson 2, David Albert 3, Michael Hanrahan 4, Mary Taylor 5, Steve Freng 6, John Ohta 7, Margaret Soukup 8, Geoff Miller
Implementation of Point-of-Care Rapid Urine Testing for Drugs of Abuse in the Emergency Department of an Academic Medical Center
Clinical Chemistry / POC Testing f o r Dr u g s o f Ab u s e in t h e ED Implementation of Point-of-Care Rapid Urine Testing for Drugs of Abuse in the Emergency Department of an Academic Medical Center
15.110 ALCOHOL AND DRUG TESTING OF DEPARTMENT PERSONNEL
15.110 ALCOHOL AND DRUG TESTING OF DEPARTMENT PERSONNEL Reference: Administrative Regulation #52 (06/07) Manual of Rules and Regulations: 1.01, 1.02, 2.26 A/B, 6.01, 6.02 A/B, 6.03, 6.04, 6.05, 11.03 Public
BLOOD DONOR TESTING & LOOKBACK STUDIES Shan Yuan, MD Last Updated 2/8/2011. 1. ABO Typing: Performed each time with each donation
Testing Performed: BLOOD DONOR TESTING & LOOKBACK STUDIES Shan Yuan, MD Last Updated 2/8/2011 1. ABO Typing: Performed each time with each donation 2. Rh Typing: o Performed along with ABO typing to determine
Performance Evaluation of Four On-Site Drug-Testing Devices for Detection of Drugs of Abuse in Urine
Journal of Analylical Toxicology, Vol. 24, October 2000 Performance Evaluation of Four On-Site Drug-Testing Devices for Detection of Drugs of Abuse in Urine Michelle R. Peace 1, Lisa D. TarnaP, and Alphonse
CURRICULUM MAP. COURSE TITLE: Health DESCRIPTION PREREQUISITES: None
CURRICULUM MAP COURSE TITLE: Health DESCRIPTION PREREQUISITES: None OF COURSE: Health Education is designed to develop an understanding of your general health and wellness. This class fosters good decision
Patterns and Trends in Drug Abuse in Los Angeles County, California: 2013
Patterns and Trends in Drug Abuse in Los Angeles County, California: 2013 Mary-Lynn Brecht, Ph.D. 1 ABSTRACT A key finding in the Los Angeles area in this reporting period was the continuing increase in
June 2016 Updated Crosswalk:
June 2016 Updated Crosswalk: 2016 HCPCS G0279 G6001 G6002 G6003 G6004 deleted f Radiology Coding BCBSNC currently considers this service investigational and will not cover either the HCPCS CPT s. Diagnostic
190.33 - Hepatitis Panel/Acute Hepatitis Panel
190.33 - Hepatitis Panel/Acute Hepatitis Panel This panel consists of the following tests: Hepatitis A antibody (HAAb), IgM antibody; Hepatitis B core antibody (HBcAb), IgM antibody; Hepatitis B surface
Emergency Medical Technicians (Basic or Intermediate - National Registry Emergency Medical Technicians and Advanced Emergency Medical Technicians )
Dear Student: Welcome to your First Responder or Emergency Medical Technician training program. Enclosed in this packet are materials that need to be completed and returned to the EMSA or handed in to
Appropriate utilization of drug tests for pain management patients
Appropriate utilization of drug tests for pain management patients Gwen McMillin, PhD, DABCC (CC, TC) Medical Director, Toxicology, ARUP Laboratories Associate Professor (clinical), University of Utah
Shipping of Infectious Substances and Patient Specimens
Shipping of Infectious Substances and Patient Specimens If you ship infectious substances or patient specimens you should be aware of the International Air Transport Association (IATA) Dangerous Goods
Drug Trends in Phoenix and Arizona: 2013
Drug Trends in Phoenix and Arizona: 213 James K. Cunningham, Ph.D. 1 ABSTRACT Two key findings for the Phoenix area (Maricopa County) in 213 were a 5-year increase in treatment admissions for other opioids
Janik, LTD d/b/a Pet Supplies Plus SUBSTANCE ABUSE POLICY
Janik, LTD d/b/a Pet Supplies Plus SUBSTANCE ABUSE POLICY Page 1 of 13 Section Table of Contents Statement of Purpose and Policy 3 I. Purpose 4 II. Provisions 4 A. Applicability 4 B. Prohibited Conduct